1. Approach to the patients with connective tIssue dIseases Müge bIçakçIgİl kalaycI

2. Connective tissue diseases (CTDs) are a group of closely related multisystem conditions, and share common signs and symptoms.
frequently makes the diagnosis of a specific rheumatic disease difficult.

3. Rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), polymyositis (PM), dermatomyositis (DM), mixed connective-tissue disease (MCTD), and Sjögren syndrome (SS) can present with similar clinical features, particularly during the first 12 months of symptoms.

4. CTDs are associated with much greater morbidity than mortality, an awareness of the potentially dangerous complications is obviously important if avoidable organ
damage and death are to be prevented.

5. KEY CLINICAL FEATURES
Many of the features of CTDs involve the skin, joints,muscles or blood vessels.
CTDs are associated with a variety of antinuclear antigens (ANA) and other related antibodies.
Internationally agreed criteria for many of the disorders have been devised,
but early in their presentation many cases do not satisfy these criteria, making diagnostic confirmation difficult

6. CONSIDERING THE DIAGNOSIS
Many initial presenting features are quite non- specific – e.g. fatigue, arthralgias, myalgias – dd(x)fibromyalgia syndrome (FMS), hypothyroidism and depression. In the early diagnosis of CTDs it is therefore important to distinguish between such non-specific features and those which are more suggestive of CTD

7. Non-specific features
Fatigue
Arthralgia
Myalgia
Depression
Malaise
Weight loss
Fever
Lymphadenopathy

8. Suggestive features Raynaud’s phenomenon Dryness of mucosal surfaces
Inflammatory arthritis
Skin rashes:
• Photosensitivity
• Mucosal ulceration
• Discoid lupus
• Skin tightness/puffiness of digits

9. Suggestive features Muscle weakness Recurrent unexplained fetal loss
(≥3, usually mid-trimester)
Pleurisy (in the absence of infection)
Vascular events (myocardial infarction,
stroke) at an early age

10. The presence of one or more of these, particularly in combination with non-specific features, increases the likelihood of a connective tissue disease. Additional investigation and/or specialist referral is then appropriate

11. Raynaud’s phenomenon
Raynaud’s phenomenon (RP) is due to variable spasm of the digital arteries. When spasm is severe, and blood flow absent, the digits appear white.
When spasm is partial and blood flow present but impaired, tissue over-extraction of capillary oxygen renders the draining blood cyanotic, so the digits appear blue.
During recovery from spasm, reactive hyperaemia makes the digits appear red, thus explaining the classic triphasic colour changes originally described.

12. Raynaud’s phenomenon
RP affects approximately 5% of the general population, and it is important to differentiate primary from secondary causes.
Primary RP usually begins during the teens and early 20s, and represents an exaggerated physiological response to cold stimuli.
It is usually not associated with any other disease entity.

13. Raynaud’s phenomenon
The development of RP at an older age (>30 years old), and especially in males, suggests the possibility that it is secondary to some underlying CTD, and this should prompt investigation for an underlying cause.

14. Raynaud’s phenomenon
RP occurs in >90% of patients with SSc and in up to 50% of cases with SLE and idiopathic inflammatory myositis (IIM).

15. Raynaud’s phenomenon
In a patient with RP any one of several additional features makes a secondary cause of RP more likely:
• year-round symptoms, or digital ulceration
• abnormal nailfold capillaries (viewed with an ophthalmoscope with the +20 lens)
• asymmetric upper limb pulses or bruits
• tightness/puffiness of the finger skin
• elevated erythrocyte sedimentation rate (ESR)
• positive ANA or other antibodies (e.g. Ro/La/Scl- 70).

17. Dryness of mucosal surfaces
Dryness of the eyes or mouth are common subjective symptoms in the general population
The menopause, diabetes mellitus and drugs such as antidepressants are all associated with such symptoms.

18. Dryness of mucosal surfaces
Having excluded these, several additional features suggest Sjögren’s syndrome, which may occur alone or in association with other CTDs:
persistence of daily ocular or oral dryness >3 months
• recurrent sensation of sand/gravel in the eyes

19. Mucosal ulcers
Sicca symptoms-

20. Dryness of mucosal surfaces
using tear substitutes >3 times a day
• frequently drinking liquids to aid food swallowing
• recurrent or persistent salivary gland swelling or infections in an adult
• abnormal Schirmer’s test
• elevated ESR or positive antibodies (ANA/Ro/La).

21. Inflammatory arthritis
Joint inflammation is associated with joint pain and stiffness (>1 hour) as well as objective evidence of soft tissue joint swelling
This needs to be distinguished from arthralgia, which often occurs in common conditions mimicking CTDs (e.g. FMS, hypothyroidism).
in addition to rheumatoidarthritis, this may also be a presenting feature of the CTDs.

22. Skin rashes The classic skin rashes associated with CTDs include:
• Photosensitivity
Abnormal sensitivity to sunshine resulting in a diffuse erythematous eruption with or without blistering.
This rash frequently involves the bridge of the nose and malar area, and classically spares the nasolabial folds.

24. Skin rashes Recurrent mucosal ulceration
Clinically these ulcers resemble idiopathic aphthous mouth ulcers, and may involve the nasal mucosa.
Discoid lupus
A discrete, raised rash associated with hyperkeratosis.
It frequently results in cutaneous scarring and pigmentary changes.

25. Skin rashes Discoid lupus
It is often photosensitive, and when it involves the scalp patchy hair loss is usually permanent

27. Raynaud’s phenomenon Livedo reticularis
Diffuse alopecia is seen in the scalp of this patient with systemic lupus erythematosus. Diffuse hair loss is most common in systemic lupus, although patchy baldness can appear. The hair usually regrows slowly when the disease becomes inactive. Not seen in this slide are the short hairs with a cut-off appearance, found in the frontal scalp area, that are typical of alopecia. Localized lesions of discoid lupus may damage hair follicles and result in permanent alopecia. 27

28. Alopecia
diffuse or patchy

29. Skin rashes Skin tightening
In SSc there is initial puffiness and oedema of the skin, particularly affecting the fingers,dorsum of hand and forearm.
There is loss of definition of the skin creases on the fingers.
The skin is difficult to pinch as it feels thickened and tightly bound to the deeper layers.

30. Systemic lupus erythematosus: hands, interarticular dermatitis
This 15-year-old girl with acute onset systemic lupus erythematosus has an erythematous rash over the dorsum of her hands and fingers. In addition, a bright band of erythema appears across the proximal phalanges, sparing the joints. There is also periungual erythema. Several proximal interphalangeal joints are swollen.
Systemic lupus erythematosus: hands, interarticular dermatitis 30

31. Muscle symptoms
Inflammatory muscle disease such as polymyositis and dermatomyositis (PM/DM) is clinically characterised by subjective and objective proximal muscle weakness, which may be accompanied by tenderness and wasting.
These clinical findings warrant further investigation, and an elevated creatinine kinase (CK) strongly supports the diagnosis.

32. Physical findings
Physical findings can be limited or may involve many organs. The potential physical manifestations of UCTD are best described by organ systems.

33. Physical findings
Skin - Telangiectasia, purpura, petechiae, digital ulcers or scars, sclerodactyly, acroscleroderma, calcinosis, malar rash, discoid rash, erythema nodosum, periungual erythema, alopecia, heliotrope eyelids,

36. Clinical Features
Calcinosis Digital Ulceration

40. Physical findings
Eye - Conjunctivitis, scleral-episcleral disease, uveitis, iritis, or keratoconjunctiva sicca
Salivary glands - Xerostomia or salivary gland enlargement
Reticuloendothelial - Lymphadenopathy or splenomegaly

41. Physical findings
Lungs - Rales, wheezing, pleural effusion, or pleural rub
Heart - Enlarged heart, murmur, pericardial rub, dependent edema, arrhythmia, or abnormal P2 sound
Vascular - Acrocyanosis, absent pulses, arterial and/or venous thrombosis

42. Physical findings
Gastrointestinal - Hepatomegaly, gastroesophageal disease, esophageal dysmotility, or malabsorption syndromes
Muscles - Muscle tenderness, muscle atrophy, or proximal muscle weakness

43. Physical findings
Joints - Joint tenderness, swelling, effusion, synovitis, or deformity
Nervous system - Cranial nerve palsy, peripheral motor neuropathy, sensory neuropathy, entrapment neuropathy, psychosis, or personality change

44. INVESTIGATIONS
Laboratory tests must always be interpreted in the light of the clinical context.
Approximately 5% of the general population have a clinically irrelevant, positive ANA in the serum, especially females, so a positive ANA in isolation may have no diagnostic significance.

45. INVESTIGATIONS
In contrast, someone with photosensitivity, inflammatory arthritis and recent pleurisy may have a 50% pre-test probability of SLE.

46. INVESTIGATIONS
Clinical notes review The value of this cannot be understated, since this may uncover relevant facts which were not previously thought of as important,
e.g. a history of DVT, recurrent miscarriages, mouth ulcers.

47. INVESTIGATIONS Full blood count and differential white cell count
This may demonstrate leucopenia (<4.0 x 109/l), lymphopenia (<1.5 x 109/l), thrombocytopenia (<100 x 109/l), or evidence for haemolysis.

48. Urine dipstick and renal function These should always be performed when a CTD is suspected.

49. Creatinine kinase
While this is often normal in cases of PM/DM, an elevated result in the context of muscle symptoms and signs clearly requires further investigation.

50. Acute phase response
The ESR is frequently raised in the CTDs, while in contrast the C-reactive protein may be normal, particularly in SLE.

51. Serology
the best screening test is the ANA. It is positive in up to 90% of patients with CTD. Other antibodies may also suggest a particular type of CTD or pattern of organ involvement

52. RF, ANA, and VDRL.
Other studies to consider, if clinically indicated, would be , C3, C4, Jo-1 antibody, anti-SSA antibody, anti-SSB antibody, Smith antibody, RNP, antitopoisomerase antibody, sclerosis (Scl)-70 antibody, and anticardiolipin antibody.

53. Imaging Studies
Findings on chest x-ray (CXR) in patients with cardiopulmonary signs and symptoms can be normal or can show evidence of mediastinal lymphadenopathy, interstitial lung disease, pleural effusion, pulmonary infiltrate, pericardial effusion, or cardiac chamber enlargement.

54. Imaging Studies
Computed tomography (CT) scan, especially high-resolution CT scan, can define anatomical intrapulmonary abnormalities more clearly.

55. Other Tests
Pulmonary function tests, including total lung volumes and carbon monoxide diffusion capacity, will assist in identifying patients with interstitial lung disease or reactive airway disease.

56. Other Tests
Echocardiogram can best clarify chamber sizes and function, estimate physiologic pressures, and identify and quantitate the size of a pericardial effusion.
The Schirmer test is useful to screen for dry eyes secondary to decreased tearing in association with primary or secondary Sjögren syndrome. This test also can have an abnormal result in patients taking medications that have anticholinergic side effects.

57. Other Tests
Rose Bengal stain of the cornea can detect keratitis associated with Sjögren syndrome.
Nailfold capillary microscopy may demonstrate dilated tortuous capillary loops and areas of avascularity ("dropout") in patients with secondary Raynaud syndrome associated with an underlying connective- tissue disease, particularly systemic sclerosis, polymyositis/dermatomyositis, and mixed connective-tissue disease.

58. Definite Connective-Tissue Disease Association
Presenting Signs or Symptoms
Presenting Laboratory Data
Systemic lupus erythematosus
Fever, photosensitivity, serositis, alopecia
ANA, dsDNA*, anti-Smith antibodies, anti-cardiolipin antibodies, leukopenia
Systemic sclerosis
Sclerodactyly, Raynaud phenomenon
ANA with nucleolar pattern
Anti centromer, antiscl70
Sjögren syndrome
Xerostomia, xerophthalmia
Anti-SSA antibodies, Anti-SSB antibodies
Mixed connective-tissue disease
Esophageal reflux, Raynaud
ANA, anti-RNP‡ antibodies
Polymyositis/dermatomyositis
Proximal muscle weakness
+/- ANA, anti pm-scl, antiJo1, anti Mi